Zoetis Inc. (ZTS)

NYSE: ZTS · IEX Real-Time Price · USD
165.49
+0.79 (0.48%)
At close: Jan 31, 2023, 4:04 PM
165.79
+0.30 (0.18%)
Pre-market: Feb 1, 2023, 5:56 AM EST
0.48%
Market Cap 77.13B
Revenue (ttm) 8.01B
Net Income (ttm) 2.07B
Shares Out 466.07M
EPS (ttm) 4.38
PE Ratio 37.78
Forward PE 30.12
Dividend $1.30 (0.79%)
Ex-Dividend Date Jan 19, 2023
Volume 2,621,319
Open 164.50
Previous Close 164.70
Day's Range 162.62 - 165.71
52-Week Range 124.15 - 205.31
Beta 0.72
Analysts Buy
Price Target 212.87 (+28.63%)
Earnings Date Feb 14, 2023

About ZTS

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives... [Read more]

Sector Healthcare
IPO Date Feb 1, 2013
Employees 12,100
Stock Exchange NYSE
Ticker Symbol ZTS
Full Company Profile

Financial Performance

In 2021, Zoetis's revenue was $7.78 billion, an increase of 16.49% compared to the previous year's $6.68 billion. Earnings were $2.04 billion, an increase of 24.36%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is $212.87, which is an increase of 28.63% from the latest price.

Price Target
$212.87
(28.63% upside)
Analyst Consensus: Buy
Stock Forecasts

News

UTHR vs. ZTS: Which Stock Is the Better Value Option?

UTHR vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: UTHR
4 days ago - Zacks Investment Research

Final Trades: Abbott Labs, SL Green, Zoetis & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols: ABTSLGJPM
2 weeks ago - CNBC Television

COLL vs. ZTS: Which Stock Is the Better Value Option?

COLL vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: COLL
2 weeks ago - Zacks Investment Research

Zoetis CEO Kristin Peck on veterinary workforce challenges and recession resilience of pet industry

Kristin Peck, CEO of Zoetis, joins 'The Exchange' to discuss the pandemic pet boom, demographic shifts among pet owners, and the labor capacity issues associated with veterinary services.

3 weeks ago - CNBC Television

The 7 Most Undervalued Value Stocks to Buy Now

Investors are entering a new era that could very well be dominated by value investing for quite some time. As a result, investors should look for undervalued value stocks to buy now.

Other symbols: CDARKHCKOPFEURI
3 weeks ago - InvestorPlace

Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on record

In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.

1 month ago - Market Watch

7 Long-Term Stocks to Put on Your Buy List in 2023

2022 wasn't a banner year for most investors. Major American equity markets fell into bear market territory.

Other symbols: HEIHIFSNFLXROPURIV
1 month ago - InvestorPlace

ASRT vs. ZTS: Which Stock Is the Better Value Option?

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: ASRT
1 month ago - Zacks Investment Research

Zoetis CEO on egg price increases

Cramer spoke with Zoetis CEO Kristin Peck on Thursday.

1 month ago - CNBC Television

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2022 Financial Results

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023. Chief Executive Officer Kristin Peck and Executive Vice...

1 month ago - Business Wire

Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. Kristin Peck, Chief Executive Officer, wil...

1 month ago - Business Wire

JPMorgan's bullish call on biopharma

The "Halftime Report" traders debate the biggest analyst calls of the day.

Other symbols: ABBVIBBLLYMRK
1 month ago - CNBC Television

7 Best Bargain Stocks to Buy in 2023

2022 was a year of soaring consumer prices and falling stock prices. I'm sure most investors will be happy to put it behind them, perhaps after some tax-loss harvesting.

Other symbols: ADBECCRDCFIMOMOSTHO
1 month ago - InvestorPlace

ASRT or ZTS: Which Is the Better Value Stock Right Now?

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: ASRT
1 month ago - Zacks Investment Research

Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the first quarter of 2023, an increase of 15% from the quarterly d...

1 month ago - Business Wire

Zoetis to Participate in the Piper Sandler 34th Annual Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022. Glenn David, Executive Vice Preside...

2 months ago - Business Wire

6 Healthcare Stocks With Room to Climb

Zoetis and Medtronic are among the healthcare stocks with the most room to rise, according to Wall Street analysts' average price targets.

Other symbols: BAXCNCCVSEWMDT
2 months ago - Barrons

Zoetis Announces Pricing of $1.35 Billion of Senior Notes

PARSIPPANY, N.J.

3 months ago - Business Wire

ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: ASRT
3 months ago - Zacks Investment Research

Demand for animal medicine remains fundamentally strong, says Zoetis CEO Kristin Peck

Zoetis CEO Kristin Peck joins 'Closing Bell' to discuss Zoetis stocks dropping after a worse than expected earnings report, the supply constraints that has been adding pressure to key growth drivers, ...

3 months ago - CNBC Television

Zoetis' (ZTS) Lags Q3 Earnings Estimates, Lowers 2022 Guidance

Zoetis' (ZTS) earnings miss estimates in third-quarter 2022. Revenues, though up, also miss estimates due to the supply constraints in the international market.

3 months ago - Zacks Investment Research

Zoetis (ZTS) Q3 Earnings and Revenues Miss Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of -2.42% and 3.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Zoetis Announces Third Quarter 2022 Results

PARSIPPANY, N.J.

3 months ago - Business Wire

Why Zoetis (ZTS) Might Surprise This Earnings Season

Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

3 months ago - Zacks Investment Research

Zoetis (ZTS) to Report Q3 Earnings: Is a Beat in Store?

Zoetis (ZTS) is anticipated to report positive earnings and revenues for third-quarter 2022. It will also provide an update on its pipeline on the earnings call.

3 months ago - Zacks Investment Research